Novavax, Inc. (NVAX) Reports Q3 Loss of $0.03
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $8.94 +6.18%
Financial Fact:
Interest expense: -3.51M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Interest expense: -3.51M
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Novavax, Inc. (NASDAQ: NVAX) reported Q3 EPS of ($0.03), $0.02 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $5 million versus the consensus estimate of $5.37 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Novavax (NVAX) 11K contracts of August 28 weekly 9 calls trade, share price up 8.8%
- ZKH Group Limited (ZKH) Reports Q2 EPS of $0.04
- Marti Technologies (MRT) Misses Q2 EPS by 9c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
